GRANDFIELD & DODD, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
GRANDFIELD & DODD, LLC portfolio value:
$20.85M
portfolio value
GRANDFIELD & DODD, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.41% | 998 shares | 3.55M | $688.87 | 30.27K |
| Q2 2022 | share | Increase | +1.74% | 500 shares | -2.8M | $591.13 | 29.27K |
| Q1 2022 | share | Increase | +3.51% | 977 shares | 2.55M | $698.42 | 28.77K |
| Q4 2021 | share | Increase | +6.78% | 1.76K shares | 1.8M | $642.51 | 27.79K |
| Q3 2021 | share | Increase | +20.31% | 4.39K shares | 3.67M | $605.18 | 26.03K |
| Q2 2021 | share | Increase | +16.56% | 3.07K shares | 3.3M | $558.54 | 21.63K |
| Q1 2021 | share | Increase | +4.55% | 807 shares | 200K | $473.14 | 18.56K |
| Q4 2020 | share | Increase | +6.51% | 1.08K shares | -750K | $483.11 | 17.75K |
| Q3 2020 | share | Increase | +0.05% | 9 shares | -1.06M | $559.78 | 16.67K |
| Q2 2020 | share | Decrease | -2.48% | -423 shares | 2.04M | $623.65 | 16.66K |
| Q1 2020 | share | Increase | +7.01% | 1.11K shares | 2.34M | $488.29 | 17.08K |
| Q4 2019 | share | Increase | +17.24% | 2.34K shares | 2.21M | $375.48 | 15.96K |
| Q3 2019 | share | Increase | +17.41% | 2.01K shares | 147K | $277.4 | 13.61K |
| Q2 2019 | share | Increase | +29.18% | 2.62K shares | -57K | $313 | 11.59K |
| Q1 2019 | share | Increase | +3.25% | 283 shares | 439K | $410.62 | 8.97K |
| Q4 2018 | share | Increase | +21.22% | 1.52K shares | 350K | $373.5 | 8.69K |
| Q3 2018 | share | Increase | +22.70% | 1.32K shares | 881K | $404.04 | 7.17K |
| Q2 2018 | share | Increase | +139.10% | 3.40K shares | 1.17M | $344.99 | 5.84K |
| Q1 2018 | share | Increase | +41.00% | 711 shares | 190K | $344.36 | 2.44K |
| Q4 2017 | share | Increase | +5.28% | 87 shares | -84K | $375.96 | 1.73K |
| Q3 2017 | share | Increase | +7.51% | 115 shares | -16K | $447.12 | 1.64K |
| Q2 2017 | share | Increase | +2.34% | 35 shares | 172K | $491.14 | 1.53K |
| Q1 2017 | share | Increase | +1.15% | 17 shares | 37K | $387.51 | 1.49K |
| Q4 2016 | share | Increase | +13.85% | 180 shares | 20K | $367.09 | 1.48K |
| Q3 2016 | share | Increase | +10.64% | 125 shares | 113K | $402.02 | 1.3K |
| Q2 2016 | share | Increase | +4.26% | 48 shares | 4K | $349.23 | 1.17K |
| Q1 2016 | share | Increase | +44.49% | 347 shares | -17K | $360.44 | 1.12K |